The 4 analysts offering 12-month price forecasts for MiMedx Group Inc have a median target of 11.63, with a high estimate of 14.00 and a low estimate of 11.00. The median estimate represents a +53.16% increase from the last price of 7.59.
The current consensus among 3 polled investment analysts is to Buy stock in MiMedx Group Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.03
Reporting Date Nov 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.